These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 32411313)

  • 1. Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis.
    Dimopoulos G; de Mast Q; Markou N; Theodorakopoulou M; Komnos A; Mouktaroudi M; Netea MG; Spyridopoulos T; Verheggen RJ; Hoogerwerf J; Lachana A; van de Veerdonk FL; Giamarellos-Bourboulis EJ
    Cell Host Microbe; 2020 Jul; 28(1):117-123.e1. PubMed ID: 32411313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.
    Loscocco GG
    Int J Hematol; 2020 Jul; 112(1):125-126. PubMed ID: 32474804
    [No Abstract]   [Full Text] [Related]  

  • 3. The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19.
    Loscocco GG; Malandrino D; Barchiesi S; Berni A; Poggesi L; Guglielmelli P; Vannucchi AM
    Int J Lab Hematol; 2020 Dec; 42(6):e270-e273. PubMed ID: 32776691
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.
    Meng M; Chen L; Zhang S; Dong X; Li W; Li R; Deng Y; Wang T; Xu Y; Liu J; Huang Y; Chen Y; Huang S; Wen Z; Zhang L; Du H; Liu Y; Annane D; Qu J; Chen D
    BMC Infect Dis; 2021 Apr; 21(1):398. PubMed ID: 33926377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reply to the letter by Gaetano Loscocco, Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.
    Takami A
    Int J Hematol; 2020 Jul; 112(1):127. PubMed ID: 32468178
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19.
    Takami A
    Int J Hematol; 2020 Jul; 112(1):122-124. PubMed ID: 32399895
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report.
    Tholin B; Hauge MT; Aukrust P; Fehrle L; Tvedt TH
    J Med Case Rep; 2020 Oct; 14(1):187. PubMed ID: 33054818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr Virus Versus Novel Coronavirus-Induced Hemophagocytic Lymphohistocytosis: The Uncharted Waters.
    Amir R; Kichloo A; Singh J; Bhanot R; Aljadah M; Kumar A; Albosta MS; Solanki S
    J Investig Med High Impact Case Rep; 2020; 8():2324709620950107. PubMed ID: 32787459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.
    Prilutskiy A; Kritselis M; Shevtsov A; Yambayev I; Vadlamudi C; Zhao Q; Kataria Y; Sarosiek SR; Lerner A; Sloan JM; Quillen K; Burks EJ
    Am J Clin Pathol; 2020 Sep; 154(4):466-474. PubMed ID: 32681166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of severe COVID-19 with subcutaneous anakinra as a sole treatment.
    González-García A; García-Sánchez I; Lopes V; Moreno-Arrones OM; Tortosa-Cabañas M; Elías-Sáenz I; Hernández-Rodríguez J
    Rheumatology (Oxford); 2020 Aug; 59(8):2171-2173. PubMed ID: 32568376
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemophagocytic lymphohistiocytosis in COVID-19: Case reports of a stepwise approach.
    Schnaubelt S; Tihanyi D; Strassl R; Schmidt R; Anders S; Laggner AN; Agis H; Domanovits H
    Medicine (Baltimore); 2021 Mar; 100(12):e25170. PubMed ID: 33761694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19.
    Faguer S; Del Bello A; Abravanel F; Nicolau-Travers ML; Kamar N
    Ann Intern Med; 2020 Sep; 173(6):501-503. PubMed ID: 32432518
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 Associated Hemophagocytic Lymphohistiocytosis and Coagulopathy: Targeting the Duumvirate.
    Bhattacharjee S; Banerjee M; Pal R
    Indian Pediatr; 2020 Sep; 57(9):827-833. PubMed ID: 32583809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19.
    Cauchois R; Koubi M; Delarbre D; Manet C; Carvelli J; Blasco VB; Jean R; Fouche L; Bornet C; Pauly V; Mazodier K; Pestre V; Jarrot PA; Dinarello CA; Kaplanski G
    Proc Natl Acad Sci U S A; 2020 Aug; 117(32):18951-18953. PubMed ID: 32699149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients.
    Lorenz G; Moog P; Bachmann Q; La Rosée P; Schneider H; Schlegl M; Spinner C; Heemann U; Schmid RM; Algül H; Lahmer T; Huber W; Schmaderer C
    Sci Rep; 2020 Oct; 10(1):18277. PubMed ID: 33106497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rationales for using JAK 1/2 inhibitors in severely afflicted patients with COVID-19 pneumonia].
    Hasselbalch HC; Poulsen A; Skov V; Kjær L; Nielsen CH; Poulsen TD
    Ugeskr Laeger; 2020 Jun; 182(25):. PubMed ID: 32584762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report.
    Franzetti M; Pozzetti U; Carugati M; Pandolfo A; Molteni C; Faccioli P; Castaldo G; Longoni E; Ormas V; Iemoli E; Piconi S
    Int J Infect Dis; 2020 Aug; 97():215-218. PubMed ID: 32422376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of anakinra in severe COVID-19: A case report.
    Filocamo G; Mangioni D; Tagliabue P; Aliberti S; Costantino G; Minoia F; Bandera A
    Int J Infect Dis; 2020 Jul; 96():607-609. PubMed ID: 32437934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].
    Deng Y; Lu S; Zhang G; Sun W; Chu Y; Meng M; Cui Y; Li P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):793-799. PubMed ID: 37593855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking IL-1 to prevent respiratory failure in COVID-19.
    van de Veerdonk FL; Netea MG
    Crit Care; 2020 Jul; 24(1):445. PubMed ID: 32682440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.